AKIP1 and plasma cell myeloma: In previous studies, the AKIP1 gene and the protein it encoded were reported as novel biomarkers and as involved in the progression and prognosis of patients with cancers, including glioma, multiple myeloma, and thyroid carcinoma [26,27,28].